Skip to Content

Urologix Inc ULGX

Morningstar Rating
$0.00 0.00 (9,900.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ULGX is trading at a 588% premium.
Price
$0.00
Fair Value
$7.56
Uncertainty
Extreme
1-Star Price
$8.12
5-Star Price
$1.16
Economic Moat
Rxv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ULGX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$2,181.77
Volume/Avg
14,550 / 7,850

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Urologix Inc is a United States-based company engaged in the development, manufacturing, and marketing of minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The firm markets the Cooled ThermoTherapy (CTC) product line and the Prostiva Radio Frequency (RF) Therapy System (Prostiva). The CTC produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva delivers radio frequency energy directly into the prostate destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH voiding symptoms. The CTC product line includes the CoolWave and Targis Control Units and the CTC Advance catheter.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
61

Valuation

Metric
ULGX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ULGX
Quick Ratio
0.31
Current Ratio
0.56
Interest Coverage
−5.12
Quick Ratio
ULGX

Profitability

Metric
ULGX
Return on Assets (Normalized)
−27.09%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
ULGX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
TzvffkslqHntvxv$181.3 Bil
Stryker Corp
SYK
VzydwkpfgGvp$129.3 Bil
Boston Scientific Corp
BSX
DjfncvbtGwffh$114.2 Bil
Medtronic PLC
MDT
HfjrqmmvXthhbh$100.0 Bil
Edwards Lifesciences Corp
EW
KhvptbgrmwZxvrlm$54.8 Bil
DexCom Inc
DXCM
CmwhqqrkMzsd$45.2 Bil
Koninklijke Philips NV ADR
PHG
PslzhxtkFbqtmz$25.1 Bil
Zimmer Biomet Holdings Inc
ZBH
XsswzgqgZwg$22.4 Bil
Steris PLC
STE
KhklyhrpsDtxwt$21.9 Bil
Align Technology Inc
ALGN
HnbgvndwFkxntc$18.3 Bil

Sponsor Center